Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-103130
Filing Date
2025-10-28
Accepted
2025-10-28 16:37:59
Documents
2
Period of Report
2025-10-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0262869-6k_nlspharma.htm 6-K 17259
2 PRESS RELEASE TITLED: "NLS PHARMACEUTICS AND KADIMASTEM ANNOUNCE COMPLETION OF M ea026286901ex99-1_nlspharma.htm EX-99.1 13648
  Complete submission text file 0001213900-25-103130.txt   32008
Mailing Address THE CIRCLE 6 8058 ZURICH Switzerland
Business Address THE CIRCLE 6 8058 ZURICH Switzerland 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 251425418
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)